Klinične študije za BOPC v Kalifornija
26 študij za BOPC išče udeležence na lokacijah v Kalifornija.
Mesta v Kalifornija
- Los Angeles9 študij
- Newport Beach8 študij
- San Francisco5 študij
- San Diego4 študij
- Santa Clarita3 študij
- Long Beach3 študij
- Buena Park3 študij
- Mountain View3 študij
Uradno besedilo študije (angleško)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Castroville
- Research Site, Garden Grove
- Research Site, Inglewood
- in še 12
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ark Clinical Research- Site Number : 8400113, Long Beach
- Inglewood Clinical- Site Number : 8400074, Los Angeles
- Alliance Clinical - West Hills- Site Number : 8400067, Los Angeles
- in še 2
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- California Medical Research Associates Inc., Northridge
Vključevanje udeležencevFaza 2
Starost 40–85 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- NewportNativeMD, Inc., Newport Beach
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
Vključevanje udeležencevFaza 2
Starost 40–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- IMAX Clinical Trials- Site Number : 8400109, La Palma
- Long Beach Research Institute- Site Number : 8400027, Long Beach
- Downtown L.A. Research Center- Site Number : 8400009, Los Angeles
- in še 3
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Newport Native MD- Site Number : 8403003, Newport Beach
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07793409A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Los Angeles
Vključevanje udeležencevFaza 2
Starost 40–80 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Los Angeles
- Research Site, Newport Beach
- Research Site, Norco
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Los Angeles
- Research Site, Palo Alto
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Garden Grove
- Research Site, Newport Beach
- Research Site, Torrance
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- Stanford Center for Excellence in Pulmonary Biology, Palo Alto
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- IMAX Clinical Trials, La Palma
- NewportNativeMD, Inc., Newport Beach
- California Medical Research Associates, Northridge
- in še 1
Vključevanje udeležencevFaza 2/3
Starost 35–80 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 100, Los Angelas
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT07555483STRIVE Post-Market Registry Study
- El Camino, Taft Center for Clinical Research, Mountain View
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of California, Los Angeles, Los Angeles
Vključevanje udeležencevFaza 3
Starost 40 in več · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Newport Beach
Vključevanje udeležencevFaza 3
Starost 40–75 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07177339Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
- San Francisco VA Medical Center, San Francisco
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40–75 · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT04722835A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- University of California, San Francisco, San Francisco
Vključevanje udeležencev
Starost 22 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT07119229The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- UCSD Sleep Research, La Jolla
Vključevanje udeležencevFaza 2
Starost 40–79 · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05237505SPIROMICS Study of Early COPD Progression (SOURCE)
- University of California Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 30–55 · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05033990Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of California at Davis, Sacramento
Vključevanje udeležencev
Starost 40–84 · Vsi spoli · Posodobljeno 24. apr. 2026 · NCT06891755PiMZ Longitudinal Cohort (PiMZ Logic)
- University of California- Los Angeles, Los Angeles
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 16. jan. 2026 · NCT06505603Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- Zuckerberg San Francisco General (ZSFG) Hospital, San Francisco
- Maxine Hall Health Center (MHHC), San Francisco
- Southeast Health Center (SEHC), San Francisco
Vključevanje udeležencev
Starost 40–90 · Vsi spoli · Posodobljeno 1. dec. 2025 · NCT05572632Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Science 37, Los Angeles
Vključevanje udeležencevOpazovalna študija
Starost 50 in več · Vsi spoli · Posodobljeno 5. avg. 2025 · NCT06122077Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
- Arthur F Gelb MD, Lakewood
- Arthur F Gelb MD, Lakewood
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 30 in več · Vsi spoli · Posodobljeno 27. okt. 2023 · NCT03263130Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.